Scaling theranostics through access, safety and trust (Sponsored)
The Top Line4 Touko

Scaling theranostics through access, safety and trust (Sponsored)

Theranostics is transforming cancer care, but scaling these treatments requires overcoming operational and workforce challenges. In this episode of The Top Line, Curium’s Mike Patterson discusses how access, safety and trust are shaping the next phase of growth for targeted radiopharmaceutical therapies.

Patterson explains why strong coordination across ordering, manufacturing and distribution is essential to delivering therapies on time. He also explores how building trust with physicians, care teams and patients requires education, consistent communication and reliable support at every stage of the treatment process.

As theranostics expands into community settings, new challenges are emerging. Workforce shortages, training needs and the importance of standardized practices are key considerations for scaling safely. Patterson shares how industry collaboration can help address these gaps while maintaining high standards of care.

He also outlines a future defined by greater access, reduced travel burdens and a more seamless patient experience. Listen to the full episode to learn how Curium is working to make theranostics more accessible across the United States.

See omnystudio.com/listener for privacy information.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(100)

How we picked the Fierce 15

How we picked the Fierce 15

What does it mean to be a Fierce 15 biotech in 2026? With this year’s list unveiled, the Fierce Biotech team gets together to discuss what the winners tell us about the state of the sector.In this wee...

9 Loka 23min

Locking in on pharma’s consumerization trend

Locking in on pharma’s consumerization trend

With GLP-1s paving the way, a consumer shift is happening across markets for certain branded pharmaceuticals. Now, the CEO of a buzzy pattern-hair-loss biotech is eyeing opportunities in an evolving m...

2 Loka 18min

Fierce Pharma Week: A look at the biggest trends, campaigns and conversations

Fierce Pharma Week: A look at the biggest trends, campaigns and conversations

Fierce Pharma Week brought thousands of people to Philadelphia for four days of conversations about pharma marketing, commercialization, medical affairs and communications. In this episode of "The Top...

25 Syys 24min

Inside the growing world of biopharma prediction markets

Inside the growing world of biopharma prediction markets

Prediction markets are opening up new ways to bet on biopharma events, from clinical trial readouts to FDA approvals. But they also create a new set of risks for an industry where employees, researche...

18 Syys 23min

Clinical trials reach a new automation inflection point (Sponsored)

Clinical trials reach a new automation inflection point (Sponsored)

Clinical development organizations are facing mounting pressure to do more with increasingly complex protocols, larger data sets and tighter timelines. While automation has improved individual process...

14 Syys 17min

The future of RAS inhibitors

The future of RAS inhibitors

Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach...

11 Syys 29min

The people who stayed with the problem

The people who stayed with the problem

The 2026 Fierce 50 includes people and organizations working on very different problems across biopharma and healthcare, from designing new proteins and developing cancer medicines to protecting vacci...

4 Syys 25min

Why Diagnostic-Driven Therapies Still Miss Eligible Patients (Sponsored)

Why Diagnostic-Driven Therapies Still Miss Eligible Patients (Sponsored)

The promise of precision medicine depends on more than scientific innovation. It also depends on whether eligible patients can be identified, tested and connected to the most appropriate treatment. In...

2 Syys 13min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
vallattomat
aikalisa
politiikan-puskaradio
rss-viihde-media
rss-ootsa-kuullut-tasta
ootsa-kuullut-tasta-2
rss-vaalirankkurit-podcast
rss-voi-venaja
the-ulkopolitist
tervo-halme
otetaan-yhdet
rss-asiastudio
rss-kaikki-uusiksi
rss-ulkopoditiikkaa
rss-toisten-taskuilla
rss-vihrea-tuuma
rss-raha-talous-ja-politiikka
rss-girls-finish-f1rst
rss-podme-livebox